Dicerna Pharmaceuticals Inc. (DRNA) Climbed 5.68% or 0.73 To Price $13.58 On Wednesday


Dicerna Pharmaceuticals Inc. (DRNA) climbed 5.68% or 0.73 to $13.58. It is close to 106754 shares traded, which is 17.56% compare to the average total volume 607812. The market cap of DRNA is $851.90 million. The year to date change is 42.97%. The 52 week price range is from $6.8 to $17.98. Price of DRNA have changed -7.42% during last week. It have changed -4.10% over last month, -20.43% over last 3 months, 2.15% over last 6 months and 66.88% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DRNA is 13.72. It is 1.03% above current price. The 200-day Moving Averages for DRNA is 13.45. It is -0.96% below current price. The stock is at support level of 200-day moving averages. The 52-week High is 17.98. It is 32.40% from the current price. The 52-week Low is 6.8. It is -49.93% from current price.

There are some statistics of DRNA. It is has market cap $851.90 million. The share outstanding is 62.73 million. The average volume is 607812. The percent of top 15 Institution holding is 105.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DRNA is -121.92%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DRNA is -69.60%.


Tags:

Share this post